Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Nat Genet. 2009 Dec 27;42(2):170–174. doi: 10.1038/ng.512

Table.

Phenotypic characteristics of subjects with CMT2C

Patient Age
(yr)
Sex Age of
onset
(yr)
First
symptom
Vocal fold
paresis
Limb weakness Sensory
loss
Hearing
loss
Proximal Distal
F1 III2 71 F 44 Foot weakness Mild None Moderate Minimal Yes
F1 IV2 48 F 5 Foot weakness Moderate Mild Severe Mild No
F1 IV3 46 F 5 Stridor Moderate Mild Moderate Mild No
F1 IV4 44 F 3 Foot weakness Severe Severe Severe Moderate Yes
F1 V1 24 F 7 Foot weakness ND None Mild Mild No
F1 V3 20 F 5 Stridor ND None Mild Mild No
F1 V8 18 M 2 Stridor Severe None Mild Minimal No
F2 III11 65 M 57 Hearing loss Mild None Mild Minimal Yes
F2 III18 61 M 34 Foot weakness Mild Mild Moderate Minimal Yes
F2 III22 64 F 35 Foot weakness Mild Mild Severe Minimal Yes
F2 III23 57 F 22 Foot weakness Moderate None Mild Minimal Yes
F2 III24 49 F <2 Stridor Moderate Mild Moderate Mild Yes
F2 IV2 50 M 16 Hoarseness Mild Mild Moderate Mild Yes
F2 IV5 53 M 28 Hoarseness Moderate None Mild Minimal Yes
F2 IV9 31 F 5 Stridor Moderate None Mild None No
F2 IV10 29 M 5 Hoarseness Moderate None Mild Minimal Yes
F2 IV12 29 F 2 Stridor Severe Moderate Severe Mild No

ND: not done